Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6831 USD | +1.94% | -14.24% | -51.55% |
03-27 | Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating | MT |
03-26 | Transcript : Lucid Diagnostics Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
Sales 2024 * | 5.73M 7.84M | Sales 2025 * | 16.48M 22.52M | Capitalization | 32.96M 45.05M |
---|---|---|---|---|---|
Net income 2024 * | -47M -64.24M | Net income 2025 * | -42M -57.41M | EV / Sales 2024 * | 5.75 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2 x |
P/E ratio 2024 * |
-0.68
x | P/E ratio 2025 * |
-0.82
x | Employees | 70 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 29.61% |
Latest transcript on Lucid Diagnostics Inc.
1 day | +1.94% | ||
1 week | -14.24% | ||
Current month | -15.66% | ||
1 month | -31.00% | ||
3 months | -52.23% | ||
6 months | -47.05% | ||
Current year | -51.55% |
Managers | Title | Age | Since |
---|---|---|---|
Lishan Aklog
CEO | Chief Executive Officer | 58 | 18-05-07 |
Shaun O’Neil
PSD | President | 42 | 18-06-30 |
Dennis McGrath
DFI | Director of Finance/CFO | 67 | 18-05-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Cox
BRD | Director/Board Member | 81 | 18-05-07 |
Jacque Sokolov
BRD | Director/Board Member | 69 | 21-04-28 |
Stanley Lapidus
BRD | Director/Board Member | 75 | 21-07-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.6831 | +1.94% | 123,806 |
24-04-25 | 0.6701 | -1.90% | 236,194 |
24-04-24 | 0.6831 | -5.52% | 236,067 |
24-04-23 | 0.723 | -3.70% | 269,597 |
24-04-22 | 0.7508 | -5.74% | 173,753 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.55% | 32.96M | |
+73.17% | 12.38B | |
-18.74% | 7.92B | |
+16.15% | 7.2B | |
+4.81% | 5.84B | |
+5.99% | 5.07B | |
+27.07% | 4.53B | |
-21.67% | 3.88B | |
-40.82% | 2.23B | |
+1.49% | 2.02B |
- Stock Market
- Equities
- LUCD Stock